Navina Secures $55M Series C Funding to Enhance AI Clinical Platform

Navina has successfully completed a $55 million Series C funding round, led by Goldman Sachs Alternatives, as announced in a press release. This investment brings Navina's total funding to $100 million and will be used to advance its AI-powered clinical intelligence platform.

The funding will accelerate Navina's expansion across the U.S. healthcare market and enhance its proprietary AI technology. The platform, which serves over 10,000 healthcare professionals across 1,300 clinics, aims to improve patient outcomes by providing proactive clinical intelligence.

Navina's AI copilot is designed to integrate seamlessly into clinical workflows, offering real-time, data-driven insights that support effective decision-making. The company has already established partnerships with industry leaders such as agilon health and Privia Health, and was recently recognized as Best in KLAS 2025 for Clinician Digital Workflow.